Amanote Research
Register
Sign In
FDA Is Failing to Inspect Drug and Device Makers, Government Reports Say
BMJ
doi 10.1136/bmj.39482.413137.db
Full Text
Open PDF
Abstract
Available in
full text
Date
February 7, 2008
Authors
Janice Hopkins Tanne
Publisher
BMJ
Related search
OxyContin, the FDA, and Drug Control
AMA journal of ethics
Health Policy
Ethics
Health
Issues
Legal Aspects
2017 FDA Drug Approvals
Nature Reviews Drug Discovery
Medicine
Drug Discovery
Pharmacology
FDA Approves New Drug to Reduce Risk of Stroke
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Exploring the Need for Government Energy Policy-Makers to Consider Social Impacts
International Journal of Social Research
Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
You Say “To-Ma-To,” I Say “To-Mah-To,” You Say “Covariate,” I Say…
Journal of Pediatrics
Child Health
Pediatrics
Perinatology
From the FDA: Epilepsy Drug Approved
Journal of the American Osteopathic Association, The
Medicine
Alternative Medicine
Complementary
The Vital Importance of Providing Sound Scientific Advice to Policy Makers in Government
Ukrainian Biochemical Journal
Biochemistry
Is Ethics Failing to Keep Up With Scientific Advances?
BioTechniques
Biochemistry
Biotechnology
Genetics
Molecular Biology
